Moderna is deprioritizing certain parts of its pipeline, which involves pausing work on some products and scrapping others.
Moderna to cut $1.1 billion in costs and launch 10 new products by 2027 as it charts post-Covid future
by Elite Financial Group | Sep 12, 2024 | Breaking News